Broker Regulation

A state medical association is calling on similar organizations across the nation to rise up and take action against spiraling generic drug price increases.

Doomsday scenarios advanced by industry opponents of the DOL fiduciary rule are the financial services industry exaggerating the rules potential negative consequences, 2 lawmakers say.

Zenefits is under investigation by the California Department of Insurance.

President Obama is using his last budget proposal as an opportunity to strengthen the legacy of the Patient Protection and Affordable Care Act.

The Pharmaceutical Research and Manufacturers of America, the powerful trade group that represents drug companies, says it will be amping up its advertising budget to try to dissuade both voters and lawmakers from supporting restrictions.

Brokers need to win new business by differentiating themselves from the competition. By seeking out a PPACA service solution offering, they can better retain their current books by being the trusted PPACA advisor their clients have come to expect.